脑出血后长期生存、死因及5年死亡率趋势:Tromsø研究
基于人群的巢式病例对照研究纳入219例首次脑出血患者和1095名年龄性别匹配对照,比较30天存活者的长期生存与5年死因,并分析心血管危险因素对5年死亡率的影响及20年间5年死亡率趋势。脑出血组死亡风险显著增高(HR 1.62),心血管病为首位死因,吸烟、血清胆固醇及抗凝药使用与死亡风险增加相关,5年死亡率随时间无变化。
要点
- 脑出血30天存活者长期死亡风险仍高于对照(HR 1.62)。
- 心血管病是首位死因,脑出血患者中占比22.9%。
- 吸烟、血清胆固醇及抗凝药使用与脑出血后死亡风险增加相关。
核心结论
- 脑出血患者生存率显著低于对照,主要由心血管死亡风险增加约2倍驱动。
- 吸烟、血清胆固醇和抗凝药使用与脑出血患者死亡风险增加相关。
- 脑出血患者5年死亡率在研究期间保持稳定。
研究设计与样本
- 基于人群的巢式病例对照研究,纳入Tromsø研究219例1994至2013年间首次脑出血的30天存活者及1095名年龄性别匹配无脑出血对照。
- 采用Kaplan-Meier法评估累积生存,分层Cox比例风险模型估计死亡HR及心血管危险因素与5年死亡率的关联,逻辑回归评估5年死亡率趋势。
主要发现
- 中位随访4.8年,脑出血组死亡风险高于对照(HR 1.62 [95% CI, 1.27-2.06])。
- 心血管病为首位死因,脑出血患者中占22.9%,对照中占9.0%(P<0.001)。
- 吸烟增加病例和对照的5年死亡风险(HR 1.59 [95% CI, 1.15-2.19])。
- 血清胆固醇仅与病例5年死亡率相关(HR 1.39 [95% CI, 1.04-1.86])。
- 脑出血发病时使用抗凝药增加死亡风险(HR 2.09 [95% CI, 1.09-4.00]),出血部位与死亡风险无关(HR 1.15 [95% CI, 0.56-2.37])。
关键数值与推荐
- 5年死亡率随日历年无变化(OR 1.01 [95% CI, 0.93-1.09])。
临床怎么用
- 对脑出血30天存活者应重视长期心血管风险管理,尤其控制吸烟和监测血清胆固醇。
- 发病时使用抗凝药者死亡风险较高,提示需评估抗凝相关风险。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND AND PURPOSE: Data on long-term survival after intracerebral hemorrhage (ICH) are scarce. In a population-based nested case-control study, we compared long-term survival and causes of death within 5 years in 30-day survivors of first-ever ICH and controls, assessed the impact of cardiovascular risk factors on 5-year mortality, and analyzed time trend in 5-year mortality in ICH patients over 2 decades. METHODS: We included 219 participants from the population-based Tromsø Study, who after the baseline participation had a first-ever ICH between 1994 to 2013 and 1095 age- and sex-matched participants without ICH. Cumulative survival was presented using the Kaplan-Meier method. Hazard ratios (HRs) for mortality and for the association between cardiovascular risk factors and 5-year mortality in 30-day survivors were estimated by stratified Cox proportional hazards models. Trend in 5-year mortality was assessed by logistic regression. RESULTS: Risk of death during follow-up (median time, 4.8 years) was increased in the ICH group compared with controls (HR, 1.62 [95% CI, 1.27-2.06]). Cardiovascular disease was the leading cause of death, with a higher proportion in ICH patients (22.9% versus 9.0%; P<0.001). Smoking increased the risk of 5-year mortality in cases and controls (HR, 1.59 [95% CI, 1.15-2.19]), whereas serum cholesterol was associated with 5-year mortality in cases only (HR, 1.39 [95% CI, 1.04-1.86]). Use of anticoagulants at ICH onset increased the risk of death (HR, 2.09 [95% CI, 1.09-4.00]). There was no difference according to ICH location (HR, 1.15 [95% CI, 0.56-2.37]). Five-year mortality did not change during the study period (odds ratio per calendar year, 1.01 [95% CI, 0.93-1.09]). CONCLUSIONS: Survival rates were significantly lower in cases than in controls, driven by a 2-fold increased risk of cardiovascular death. Smoking, serum cholesterol, and use of anticoagulant drugs were associated with increased risk of death in ICH patients. Five-year mortality rates in ICH patients remained stable over time.
引用
- Carlsson M, Wilsgaard T, Johnsen SH, et al. Long-Term Survival, Causes of Death, and Trends in 5-Year Mortality After Intracerebral Hemorrhage: The Tromsø Study. Stroke. 2021. PMID: 34496620. doi:10.1161/STROKEAHA.120.032750
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。